• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Kasahara Norimitsu  笠原 礼光

ORCIDConnect your ORCID iD *help
Researcher Number 10815707
Other IDs
Affiliation (based on the past Project Information) *help 2019 – 2022: 群馬大学, 医学部附属病院, 助教
Review Section/Research Field
Principal Investigator
Basic Section 50020:Tumor diagnostics and therapeutics-related
Keywords
Principal Investigator
リキッドバイオプシー / EGFR陽性非小細胞肺癌 / 非小細胞肺癌 / 肺癌 / EGFR陽性 / オシメルチニブ / EGFR遺伝子変異 / 非小細胞肺がん / バイオマーカー
  • Research Projects

    (1 results)
  • Research Products

    (6 results)
  •  Biomarker analysis of predictors of osimertinib efficacy in non-small cell lung cancerPrincipal Investigator

    • Principal Investigator
      Kasahara Norimitsu
    • Project Period (FY)
      2019 – 2022
    • Research Category
      Grant-in-Aid for Early-Career Scientists
    • Review Section
      Basic Section 50020:Tumor diagnostics and therapeutics-related
    • Research Institution
      Gunma University

All 2021 2020 2019

All Journal Article Presentation

  • [Journal Article] Glasgow prognostic score predicts efficacy and prognosis in patients with advanced non‐small cell lung cancer receiving EGFR‐TKI treatment2020

    • Author(s)
      Kasahara Norimitsu、Imai Hisao、Naruse Ichiro、Tsukagoshi Yusuke、Kotake Mie、Sunaga Noriaki、Kaira Kyoichi、Maeno Toshitaka、Asao Takayuki、Hisada Takeshi
    • Journal Title

      Thoracic Cancer

      Volume: 11 Issue: 8 Pages: 2188-2195

    • DOI

      10.1111/1759-7714.13526

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-19K16855
  • [Presentation] An exploratory study of biomarkers in blood of osimertinib for EGFR-T790M mutation-positive NSCLC2021

    • Author(s)
      Norimitsu Kasahara, Ou Yamaguchi, Hiroshi Soda, Hiroaki Masubuchi, Hisao Imai, Ichiro Naruse, Hiroyuki Yamaguchi, Kyoichi Kaira
    • Organizer
      第25回アジア太平洋呼吸器学会学術集会
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-19K16855
  • [Presentation] EGFR-T790M変異陽性NSCLCに対するオシメルチニブの血中バイオマーカー探索研究2021

    • Author(s)
      笠原礼光、山口央、早田宏、増渕裕朗、今井久雄、成清一郎、山口博之、解良恭一
    • Organizer
      第62回日本肺癌学会学術集会
    • Data Source
      KAKENHI-PROJECT-19K16855
  • [Presentation] Post-treatment Glasgow prognostic score predicts efficacy in patients with advanced non-small cell lung cancer receiving anti-PD-1 treatment2019

    • Author(s)
      Norimitsu Kasahara, Noriaki Sunaga, Yusuke Tsukagoshi, Yosuke Miura, Reiko Sakurai, Shinsuke Kitahara, Takehiko Yokobori, Kyoichi Kaira, Akira Mogi, Toshitaka Maeno, Takayuki Asao, Takeshi Hisada
    • Organizer
      第17回日本臨床腫瘍学会学術集会
    • Data Source
      KAKENHI-PROJECT-19K16855
  • [Presentation] Pembrolizumab 投与後に薬剤性筋炎を発症した肺腺癌の1例2019

    • Author(s)
      伊藤 優志、笠原 礼光、三浦 陽介、鶴巻 寛朗、矢冨 正清、原 健一郎、櫻井 麗子 、砂長 則明、前野 敏孝、久田 剛志
    • Organizer
      第60回日本肺癌学会学術集会
    • Data Source
      KAKENHI-PROJECT-19K16855
  • [Presentation] 進行非小細胞肺癌治療における 免疫チェックポイント阻害剤と免疫関連有害事象の関連2019

    • Author(s)
      笠原礼光, 砂長則明, 塚越優介, 山口公一, 三浦陽介, 増渕裕朗, 北原信介,鶴巻寛朗, 矢冨正清, 原健一郎,古賀康彦,久田剛志, 浅尾高行, 前野敏孝
    • Organizer
      第68回日本アレルギー学会学術大会
    • Data Source
      KAKENHI-PROJECT-19K16855

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi